Cite

HARVARD Citation

    Noizat‐Pirenne, F. et al. (2015). The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease. Vox sanguinis. 108 (3), pp. 262-267. [Online]. 
  
Back to record